In The News
ConstructionPRO Test 1
ConstructionPRO Test 2
ConstructionPRO Test 3
ConstructionPRO Test 4
ConstructionPRO Test 5
ConstructionPRO Test 6
ConstructionPRO Test 7
High Court rejects Qantas appeal in ground crew sacking case
I’m afraid AI can’t do that: Law firms say smart tech uses limited
Lawyer’s defamation case fails serious harm test, judge finds
Merck Sharp & Dohme lodges cross appeal in Prevnar 13 vaccine patent spat
Allens 2021-01-25 4:33 pm By Miklos Bolza Melbourne
Please login to bookmark Close

Drug giant Merck Sharp & Dohme has brought a cross appeal in its long-running intellectual property dispute with Pfizer’s Wyeth over the top selling Prevnar 13 pneumococcal vaccine.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au